Multidisciplinary management of malignant ovarian germ cell tumours

Gynecologic Oncology

Volumn 121, Issue 3, 2011, Pages 625-636

  Parkinson, C A ^a   Hatcher, H M ^a   Earl, H M ^a,b   Ajithkumar, T V ^a  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Chemotherapy; Germ cell tumours; Late effects; Ovary; Surgery; Survivorship

Indexed keywords

ALKALINE PHOSPHATASE; ALPHA FETOPROTEIN; BLEOMYCIN; CA 125 ANTIGEN; CARBOPLATIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; ETOPOSIDE; FLUORODEOXYGLUCOSE F 18; GEMCITABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; IMATINIB; IRINOTECAN; LACTATE DEHYDROGENASE; NEDAPLATIN; OXALIPLATIN; PACLITAXEL; VINBLASTINE; VINCRISTINE;

ADVANCED CANCER; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RELAPSE; CANCER RESISTANCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER SURVIVOR; CHORIOCARCINOMA; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; CYTOREDUCTIVE SURGERY; DRUG EFFICACY; DYSGERMINOMA; FEMALE FERTILITY; FOLLOW UP; GERM CELL TUMOR; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LAPAROTOMY; MALIGNANT OVARY GERM CELL TUMOR; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NEUROTOXICITY; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARIECTOMY; OVARY TERATOMA; OVARY TUMOR; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE CARE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; REPRODUCTIVE HEALTH; SECOND LOOK SURGERY; SEMINOMA; SENSITIVITY AND SPECIFICITY; SURVIVAL TIME; TERATOGENESIS; THROMBOCYTOPENIA;

EID: 79957527116     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.12.351     Document Type: Review

References (152)

1. J.T. Quirk, and N. Natarajan Ovarian cancer incidence in the United States, 1992-1999 Gynecol Oncol 97 2 May 2005 519 523 (Pubitemid 40614898)
2. C. Westhoff, M. Pike, and M. Vessey Benign ovarian teratomas: a population-based case-control study Br J Cancer 58 1 Jul 1988 93 98
3. J.S. Berek, and N.F. Hacker Nonepithelial ovarian and fallopian tube cancers J.S. Barek, N.F. Hacker, Practical gynecologic oncology Fourth ed. 2005 Lippincott Williams & Wilkins Philadelphia 511 541
4. N.R. Abu-Rustum, and C. Aghajanian Management of malignant germ cell tumors of the ovary Semin Oncol 25 2 Apr 1998 235 242 (Pubitemid 28201398)
5. F.E. von Eyben A systematic review of lactate dehydrogenase isoenzyme 1 and germ cell tumors Clin Biochem 34 6 Sep 2001 441 454 (Pubitemid 33001313)
6. R.H. Pressley, H.G. Muntz, S. Falkenberry, and L.W. Rice Serum lactic dehydrogenase as a tumor marker in dysgerminoma Gynecol Oncol 44 3 Mar 1992 281 283
7. S. Sekiya, K. Seki, and Y. Nagai Rise of serum CA 125 in patients with pure ovarian yolk sac tumors Int J Gynaecol Obstet 58 3 Sep 1997 323 324 (Pubitemid 27361879)
8. L. Elit, A. Bocking, C. Kenyon, and R. Natale An endodermal sinus tumor diagnosed in pregnancy: case report and review of the literature Gynecol Oncol 72 1 Jan 1999 123 127 (Pubitemid 29045462)
9. Y. Aoki, M. Higashino, S. Ishii, and K. Tanaka Yolk sac tumor of the ovary during pregnancy: a case report Gynecol Oncol 99 2 Nov 2005 497 499 (Pubitemid 41502868)
10. E.S. Newlands, L. Holden, and K.D. Bagshawe Tumour markers and POMB/ACE chemotherapy in the management of ovarian germ cell tumours (GCTs) Int J Biol Markers 3 3 Jul-Sep 1988 185 192
11. M.M. Altaras, G.L. Goldberg, W. Levin, L. Darge, B. Bloch, and J.A. Smith The value of cancer antigen-125 as a tumor marker in malignant germ cell tumors of the ovary Gynecol Oncol 25 2 Oct 1986 150 159 (Pubitemid 16004352)
12. M. Kawai, T. Kano, F. Kikkawa, Y. Morikawa, H. Oguchi, and N. Nakashima Seven tumor markers in benign and malignant germ cell tumors of the ovary Gynecol Oncol 45 3 Jun 1992 248 253
13. M.S. Motawy, J.J. Szymendera, H. al-Jazzaf, A.E. Behbehani, M.O. Foudeh, and A.K. Ebraheem Serum AFP, hCG and CEA in the management of patients with testicular, ovarian and extragonadal germ cell tumors Int J Biol Markers 7 2 Apr-Jun 1992 80 86
14. M. Kawata, S. Sekiya, R. Hatakeyama, and H. Takamizawa Neuron-specific enolase as a serum marker for immature teratoma and dysgerminoma Gynecol Oncol 32 2 Feb 1989 191 197 (Pubitemid 19041961)
15. Y. Tatekawa, H. Kemmotsu, T. Mouri, K. Joe, and H. Ohkawa A case of pediatric ovarian dysgerminoma associated with high serum levels and positive immunohistochemical staining of neuron-specific enolase J Pediatr Surg 39 9 Sep 2004 1437 1439 (Pubitemid 39186553)
16. T.P. Cotter, N.P. Kealy, P.F. Duggan, A. Curtain, and C.P. Bredin Elevated serum angiotensin converting enzyme levels in metastatic ovarian dysgerminoma Respir Med 91 4 Apr 1997 237 239 (Pubitemid 27168370)
17. M. Suzuki, H. Kobayashi, M. Ohwada, T. Terao, and I. Sato Macrophage colony-stimulating factor as a marker for malignant germ cell tumors of the ovary Gynecol Oncol 68 1 Jan 1998 35 37 (Pubitemid 28109820)
18. T. Ueno, Y.O. Tanaka, M. Nagata, H. Tsunoda, I. Anno, and S. Ishikawa Spectrum of germ cell tumors: from head to toe Radiographics 24 2 Mar-Apr 2004 387 404
19. H.M. Brammer III, J.L. Buck, W.S. Hayes, S. Sheth, and F.A. Tavassoli From the archives of the AFIP. Malignant germ cell tumors of the ovary: radiologic-pathologic correlation Radiographics 10 4 Jul 1990 715 724
20. Y. Tanaka, Y. Sasaki, K. Tachibana, H. Maesaka, K. Imaizumi, and H. Nishihira Gonadal mixed germ cell tumor combined with a large hemangiomatous lesion in a patient with Turner's syndrome and 45, X/46, X, + mar karyotype Arch Pathol Lab Med 118 11 Nov 1994 1135 1138 (Pubitemid 24345841)
21. M.L. Rosado-de-Christenson, P.A. Templeton, and C.A. Moran From the archives of the AFIP. Mediastinal germ cell tumors: radiologic and pathologic correlation Radiographics 12 5 Sep 1992 1013 1030
22. R.G. Levitt, J.E. Husband, and H.S. Glazer CT of primary germ-cell tumors of the mediastinum AJR Am J Roentgenol 142 1 Jan 1984 73 78 (Pubitemid 14218811)
23. M. De Santis, A. Becherer, C. Bokemeyer, F. Stoiber, K. Oechsle, and F. Sellner 2-18fluoro-deoxy-d-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: an update of the prospective multicentric SEMPET trial J Clin Oncol 22 6 Mar 15 2004 1034 1039 (Pubitemid 41095035)
24. M. de Wit, M. Hartmann, J. Kotzerke, M. Wirth, W. Brenner, and D. Hellwig 18F]-FDG-PET in clinical stage I and II non-seminomatous germ cell tumors: first results of the German Multicenter Trial J Clin Oncol 23 16S 2005 4504
25. R.A. Huddart, M.J. O'Doherty, A. Padhani, G.J. Rustin, G.M. Mead, and J.K. Joffe 18fluorodeoxyglucose positron emission tomography in the prediction of relapse in patients with high-risk, clinical stage I nonseminomatous germ cell tumors: preliminary report of MRC Trial TE22-the NCRI Testis Tumour Clinical Study Group J Clin Oncol 25 21 Jul 20 2007 3090 3095 (Pubitemid 47218056)
26. K. Tewari, F. Cappuccini, P.J. Disaia, M.L. Berman, A. Manetta, and M.F. Kohler Malignant germ cell tumors of the ovary Obstet Gynecol 95 1 Jan 2000 128 133 (Pubitemid 30001642)
27. G. Zanetta, C. Bonazzi, M. Cantu, S. Binidagger, A. Locatelli, and G. Bratina Survival and reproductive function after treatment of malignant germ cell ovarian tumors J Clin Oncol 19 4 Feb 15 2001 1015 1020 (Pubitemid 32176276)
28. J.J. Low, L.C. Perrin, A.J. Crandon, and N.F. Hacker Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors. A review of 74 cases Cancer 89 2 Jul 15 2000 391 398 (Pubitemid 30489889)
29. K. Kanazawa, T. Suzuki, and K. Sakumoto Treatment of malignant ovarian germ cell tumors with preservation of fertility: reproductive performance after persistent remission Am J Clin Oncol 23 3 Jun 2000 244 248 (Pubitemid 32428027)
30. L.C. Perrin, J. Low, J.L. Nicklin, B.G. Ward, and A.J. Crandon Fertility and ovarian function after conservative surgery for germ cell tumours of the ovary Aust N Z J Obstet Gynaecol 39 2 May 1999 243 245 (Pubitemid 29251071)
31. M.E. Beiner, W.H. Gotlieb, Y. Korach, A. Shrim, D. Stockheim, and Y. Segal Cystectomy for immature teratoma of the ovary Gynecol Oncol 93 2 May 2004 381 384 (Pubitemid 38507605)
32. V. Troche, and E. Hernandez Neoplasia arising in dysgenetic gonads Obstet Gynecol Surv 41 2 Feb 1986 74 79 (Pubitemid 16159135)
33. D.M. Gershenson Update on malignant ovarian germ cell tumors Cancer 71 4 Suppl Feb 15 1993 1581 1590 (Pubitemid 23056077)
34. L.D. Truong, S. Jurco III, and M.H. McGavran Gliomatosis peritonei. Report of two cases and review of literature Am J Surg Pathol 6 5 Jul 1982 443 449 (Pubitemid 12044742)
35. S.N. Nielsen, B.W. Scheithauer, and T.A. Gaffey Gliomatosis peritonei Cancer 56 10 Nov 15 1985 2499 2503 (Pubitemid 16202449)
36. G. Shefren, J. Collin, and O. Soriero Gliomatosis peritonei with malignant transformation: a case report and review of the literature Am J Obstet Gynecol 164 6 Pt 1 Jun 1991 1617 1620 [discussion 20-1]
37. F. Dadmanesh, D.M. Miller, K.D. Swenerton, and P.B. Clement Gliomatosis peritonei with malignant transformation Mod Pathol 10 6 Jun 1997 597 601 (Pubitemid 27293500)
38. S.C. Mengshol, L.R. Demars, and A.R. Schned Gliomatosis peritonei and teratomatous implant with carcinomatous transformation presenting 54 years following oophorectomy for dermoid cyst Gynecol Oncol 92 1 Jan 2004 353 356 (Pubitemid 38147416)
39. R.E. Slayton, R.C. Park, S.G. Silverberg, H. Shingleton, W.T. Creasman, and J.A. Blessing Vincristine, dactinomycin, and cyclophosphamide in the treatment of malignant germ cell tumors of the ovary. A Gynecologic Oncology Group Study (a final report) Cancer 56 2 Jul 15 1985 243 248 (Pubitemid 15031640)
40. S.D. Williams, J.A. Blessing, D.H. Moore, H.D. Homesley, and L. Adcock Cisplatin, vinblastine, and bleomycin in advanced and recurrent ovarian germ-cell tumors. A trial of the Gynecologic Oncology Group Ann Intern Med 111 1 Jul 1 1989 22 27 (Pubitemid 19167593)
41. P.E. Schwartz Surgery of germ cell tumours of the ovary Forum (Genova) 10 4 Oct-Dec 2000 355 365
42. S.D. Williams, J.A. Blessing, P.J. DiSaia, F.J. Major, H.G. Ball III, and S.Y. Liao Second-look laparotomy in ovarian germ cell tumors: the gynecologic oncology group experience Gynecol Oncol 52 3 Mar 1994 287 291 (Pubitemid 24125541)
43. D.M. Gershenson The obsolescence of second-look laparotomy in the management of malignant ovarian germ cell tumors Gynecol Oncol 52 3 Mar 1994 283 285 (Pubitemid 24125540)
44. S. Culine, C. Lhomme, G. Michel, J. Leclere, P. Duvillard, and J.P. Droz Is there a role for second-look laparotomy in the management of malignant germ cell tumors of the ovary? Experience at Institut Gustave Roussy J Surg Oncol 62 1 May 1996 40 45 (Pubitemid 26134530)
45. Y. Itani, M. Kawa, S. Toyoda, K. Yamagami, and K. Hiraoka Growing teratoma syndrome after chemotherapy for a mixed germ cell tumor of the ovary J Obstet Gynaecol Res 28 3 Jun 2002 166 171 (Pubitemid 35021667)
46. J.P. Geisler, R. Goulet, R.S. Foster, and G.P. Sutton Growing teratoma syndrome after chemotherapy for germ cell tumors of the ovary Obstet Gynecol 84 4 Pt 2 Oct 1994 719 721 (Pubitemid 24308892)
47. G.K. Mathew, S.S. Singh, R.G. Swaminathan, and S.G. Tenali Laparotomy for post chemotherapy residue in ovarian germ cell tumors J Postgrad Med 52 4 Oct-Dec 2006 262 265
48. L.A. Asadourian, and H.B. Taylor Dysgerminoma. An analysis of 105 cases Obstet Gynecol 33 3 Mar 1969 370 379
49. A. Gordon, D. Lipton, and J.D. Woodruff Dysgerminoma: a review of 158 cases from the Emil Novak Ovarian Tumor Registry Obstet Gynecol 58 4 Oct 1981 497 504 (Pubitemid 12232160)
50. S.J. Buskirk, M.F. Schray, K.C. Podratz, R.A. Lee, C.R. Stanhope, and T.A. Gaffey Ovarian dysgerminoma: a retrospective analysis of results of treatment, sites of treatment failure, and radiosensitivity Mayo Clin Proc 62 12 Dec 1987 1149 1157 (Pubitemid 18031824)
51. J.P. LaPolla, J. Benda, A.P. Vigliotti, and B. Anderson Dysgerminoma of the ovary Obstet Gynecol 69 6 Jun 1987 859 864 (Pubitemid 17078170)
52. G. Krepart, J.P. Smith, F. Rutledge, and L. Delclos The treatment for dysgerminoma of the ovary Cancer 41 3 Mar 1978 986 990 (Pubitemid 8313236)
53. G.G. Dark, M. Bower, E.S. Newlands, F. Paradinas, and G.J. Rustin Surveillance policy for stage I ovarian germ cell tumors J Clin Oncol 15 2 Feb 1997 620 624 (Pubitemid 27074230)
54. C. Bonazzi, F. Peccatori, N. Colombo, V. Lucchini, M.G. Cantu, and C. Mangioni Pure ovarian immature teratoma, a unique and curable disease: 10 years' experience of 32 prospectively treated patients Obstet Gynecol 84 4 Oct 1994 598 604 (Pubitemid 24311155)
55. D.M. Patterson, N. Murugaesu, L. Holden, M.J. Seckl, and G.J. Rustin A review of the close surveillance policy for stage I female germ cell tumors of the ovary and other sites Int J Gynecol Cancer 18 1 Jan-Feb 2008 43 50
56. S. Williams, J.A. Blessing, S.Y. Liao, H. Ball, and P. Hanjani Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group J Clin Oncol 12 4 Apr 1994 701 706 (Pubitemid 24110908)
57. M.A. Dimopoulos, C. Papadimitriou, G. Hamilos, E. Efstathiou, G. Vlahos, and A. Rodolakis Treatment of ovarian germ cell tumors with a 3-day bleomycin, etoposide, and cisplatin regimen: a prospective multicenter study Gynecol Oncol 95 3 Dec 2004 695 700 (Pubitemid 39592540)
58. R. De Wit, J.T. Roberson, P.M. Wilkinson, P.H. de Mulder, G.M. Mead, and S.D. Fossa Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council J Clin Oncol 19 2001 1629 1640 (Pubitemid 32230862)
59. S.D. Williams, J. Kauderer, A.F. Burnett, S.S. Lentz, C. Aghajanian, and D.K. Armstrong Adjuvant therapy of completely resected dysgerminoma with carboplatin and etoposide: a trial of the Gynecologic Oncology Group Gynecol Oncol 95 3 Dec 2004 496 499 (Pubitemid 39592510)
60. A. Horwich, D.T. Sleijfer, S.D. Fossa, S.B. Kaye, R.T. Oliver, and M.H. Cullen Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial J Clin Oncol 15 5 May 1997 1844 1852 (Pubitemid 27209513)
61. R.T. Oliver, M.D. Mason, G.M. Mead, H. von der Maase, G.J. Rustin, and J.K. Joffe Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial Lancet 366 9482 Jul 23-29 2005 293 300
62. N. Murugaesu, P. Schmid, G. Dancey, R. Agarwal, L. Holden, and I. McNeish Malignant ovarian germ cell tumors: identification of novel prognostic markers and long-term outcome after multimodality treatment J Clin Oncol 24 30 Oct 20 2006 4862 4866 (Pubitemid 46630913)
63. C.H. Lai, T.C. Chang, S. Hsueh, T.I. Wu, A. Chao, and H.H. Chou Outcome and prognostic factors in ovarian germ cell malignancies Gynecol Oncol 96 3 Mar 2005 784 791 (Pubitemid 40255502)
64. D. Billmire, C. Vinocur, F. Rescorla, B. Cushing, W. London, and M. Schlatter Outcome and staging evaluation in malignant germ cell tumors of the ovary in children and adolescents: an intergroup study J Pediatr Surg 39 3 Mar 2004 424 429 [discussion -9] (Pubitemid 38338361)
65. V. Zanagnolo, E. Sartori, G. Galleri, B. Pasinetti, and U. Bianchi Clinical review of 55 cases of malignant ovarian germ cell tumors Eur J Gynaecol Oncol 25 3 2004 315 320 (Pubitemid 38585613)
66. E. Skof, C. Grasic Kuhar, O. Cerar, and B. Zakotnik Survival and fertility of patients with malignant ovarian germ cell tumours Eur J Gynaecol Oncol 25 6 2004 702 706 (Pubitemid 39576947)
67. J.R. Germa, M.A. Izquierdo, M.A. Segui, M.A. Climent, B. Ojeda, and C. Alonso Malignant ovarian germ cell tumors: the experience at the Hospital de la Santa Creu i Sant Pau Gynecol Oncol 45 2 May 1992 153 159
68. J.M. O'Sullivan, R.A. Huddart, A.R. Norman, J. Nicholls, D.P. Dearnaley, and A. Horwich Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours Ann Oncol 14 1 Jan 2003 91 96 (Pubitemid 36150265)
69. M.S. Zaghloul, and T.Y. Khattab Dysgerminoma of the ovary: good prognosis even in advanced stages Int J Radiat Oncol Biol Phys 24 1 1992 161 165
70. F. Yilmaz, T. Gul, and A.K. Uzunlar Malignant ovarian germ cell tumors: analysis of 32 cases Eur J Gynaecol Oncol 24 6 2003 569 573 (Pubitemid 37462585)
71. A. Ayhan, Z.S. Tuncer, F. Yanik, O. Bukulmez, A. Yanik, and T. Kucukali Malignant germ cell tumors of the ovary: Hacettepe hospital experience Acta Obstet Gynecol Scand 74 5 May 1995 384 390
72. S. Kusamura, L.C. Teixeira, M.A. dos Santos, L.A. de Angelo Andrade, J.C. Campos Torres, and A. Sagarra Ovarian germ cell cancer: clinicopathologic analysis and outcome of 31 cases Tumori 86 6 Nov-Dec 2000 450 454
73. D.M. Gershenson, M. Morris, A. Cangir, J.J. Kavanagh, C.A. Stringer, and C.L. Edwards Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide, and cisplatin J Clin Oncol 8 4 Apr 1990 715 720 (Pubitemid 20127256)
74. T. de La Motte Rouge, P. Pautier, A. Rey, P. Duvillard, P. Kerbrat, and F. Troalen Prognostic factors in women treated for ovarian yolk sac tumour: a retrospective analysis of 84 cases Eur J Cancer 47 2 Jan 2011 175 182
75. B. Kong, Y.J. Tian, W.W. Zhu, and Y.J. Qin A pure nongestational ovarian choriocarcinoma in a 10-year-old girl: case report and literature review J Obstet Gynaecol Res 35 3 Jun 2009 574 578
76. A.K. Uzunlar, A. Yalinkaya, M. Yaldiz, N. Kilinc, and T. Gul Survival and reproductive function after treatment of immature ovarian teratoma Eur J Gynaecol Oncol 22 5 2001 384 386 (Pubitemid 33144551)
77. H. Li, W. Hong, R. Zhang, L. Wu, L. Liu, and W. Zhang Retrospective analysis of 67 consecutive cases of pure ovarian immature teratoma Chin Med J (Engl) 115 10 Oct 2002 1496 1500 (Pubitemid 35282909)
78. A. Nawa, N. Obata, F. Kikkawa, M. Kawai, T. Nagasaka, and S. Goto Prognostic factors of patients with yolk sac tumors of the ovary Am J Obstet Gynecol 184 6 May 2001 1182 1188 (Pubitemid 32434271)
79. S. Culine, J. Kattan, C. Lhomme, P. Duvillard, G. Michel, and D. Castaigne A phase II study of high-dose cisplatin, vinblastine, bleomycin, and etoposide (PVeBV regimen) in malignant nondysgerminomatous germ-cell tumors of the ovary Gynecol Oncol 54 1 Jul 1994 47 53 (Pubitemid 24239407)
80. K. Margolin, J.H. Doroshow, C. Ahn, V. Hamasaki, L. Leong, and R. Morgan Treatment of germ cell cancer with two cycles of high-dose ifosfamide, carboplatin, and etoposide with autologous stem-cell support J Clin Oncol 14 10 Oct 1996 2631 2637 (Pubitemid 26329646)
81. L.H. Einhorn, M.J. Stender, and S.D. Williams Phase II trial of gemcitabine in refractory germ cell tumors J Clin Oncol 17 2 Feb 1999 509 511 (Pubitemid 29075235)
82. E.R. Broun, C.R. Nichols, R. Mandanas, D. Salzman, M. Turns, and R. Hromas Dose escalation study of high-dose carboplatin and etoposide with autologous bone marrow support in patients with recurrent and refractory germ cell tumors Bone Marrow Transplant 16 3 Sep 1995 353 358
83. M.A. Dimopoulos, M. Papadopoulou, E. Andreopoulou, C. Papadimitriou, N. Pavlidis, and G. Aravantinos Favorable outcome of ovarian germ cell malignancies treated with cisplatin or carboplatin-based chemotherapy: a Hellenic Cooperative Oncology Group study Gynecol Oncol 70 1 Jul 1998 70 74 (Pubitemid 28368878)
84. M.M. Cheung, W.H. Lau, M. Chan, S.K. Teng, J.K. Chan, and R.K. Ngan Experience with the management of ovarian germ cell tumors in Chinese patients Gynecol Oncol 52 3 Mar 1994 306 312 (Pubitemid 24125545)
85. J.P. Curtin, C.P. Morrow, G. D'Ablaing, and J.B. Schlaerth Malignant germ cell tumors of the ovary: 20-year report of LAC-USC Women's Hospital Int J Gynecol Cancer 4 1 Jan 1994 29 35 (Pubitemid 24012220)
86. A. Ezzat, M. Raja, Y. Bakri, J. Subhi, M. Memon, and P. Schwartz Malignant ovarian germ cell tumours-a survival and prognostic analysis Acta Oncol 38 4 1999 455 460 (Pubitemid 29305720)
87. P.E. Schwartz, S.K. Chambers, J.T. Chambers, E. Kohorn, and S. McIntosh Ovarian germ cell malignancies: the Yale University experience Gynecol Oncol 45 1 Apr 1992 26 31
88. A. Munkarah, D.M. Gershenson, C. Levenback, E.G. Silva, M.J. Messing, and M. Morris Salvage surgery for chemorefractory ovarian germ cell tumors Gynecol Oncol 55 2 Nov 1994 217 223 (Pubitemid 24366629)
89. J. Li, W. Yang, and X. Wu Prognostic factors and role of salvage surgery in chemorefractory ovarian germ cell malignancies: a study in Chinese patients Gynecol Oncol 105 3 Jun 2007 769 775 (Pubitemid 46734209)
90. M.J. Messing, D.M. Gershenson, M. Morris, T.W. Burke, J.J. Kavanagh, and J.T. Wharton Primary treatment failure in patients with malignant ovarian germ cell neoplasms Int J Gynecol Cancer 2 6 Nov 1992 295 300
91. R.A. Mandanas, R.A. Saez, R.B. Epstein, D.L. Confer, and G.B. Selby Long-term results of autologous marrow transplantation for relapsed or refractory male or female germ cell tumors Bone Marrow Transplant 21 6 Mar 1998 569 576 (Pubitemid 28138255)
92. M. Bower, K. Fife, L. Holden, F.J. Paradinas, G.J. Rustin, and E.S. Newlands Chemotherapy for ovarian germ cell tumours Eur J Cancer 32A 4 Apr 1996 593 597
93. S. Culine, C. Lhomme, F. Farhat, and J.P. Droz Salvage chemotherapy in non-dysgerminomatous germ cell tumours of the ovary Eur J Cancer 31A 11 Oct 1995 1890 1891
94. L.C. Wong, R.J. Collins, H.Y. Ngan, and H.K. Ma Etoposide combination chemotherapy in refractory ovarian malignant germ cell tumor Gynecol Oncol 39 2 Nov 1990 123 126 (Pubitemid 20372397)
95. B.R. Murphy, E.S. Breeden, J.P. Donohue, J. Messemer, W. Walsh, and B.J. Roth Surgical salvage of chemorefractory germ cell tumors J Clin Oncol 11 2 Feb 1993 324 329 (Pubitemid 23046824)
96. P.J. Loehrer Sr., R. Gonin, C.R. Nichols, T. Weathers, and L.H. Einhorn Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor J Clin Oncol 16 7 Jul 1998 2500 2504 (Pubitemid 28309047)
97. J.A. McCaffrey, M. Mazumdar, D.F. Bajorin, G.J. Bosl, V. Vlamis, and R.J. Motzer Ifosfamide- and cisplatin-containing chemotherapy as first-line salvage therapy in germ cell tumors: response and survival J Clin Oncol 15 7 Jul 1997 2559 2563 (Pubitemid 27289885)
98. J.L. Pico, G. Rosti, A. Kramar, H. Wandt, V. Koza, and R. Salvioni A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours Ann Oncol 16 7 Jul 2005 1152 1159 (Pubitemid 41418319)
99. G.V. Kondagunta, J. Bacik, A. Donadio, D. Bajorin, S. Marion, and J. Sheinfeld Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors J Clin Oncol 23 27 Sep 20 2005 6549 6555 (Pubitemid 46190247)
100. E.R. Broun, C.R. Nichols, M. Turns, S.D. Williams, P.J. Loehrer, and B.J. Roth Early salvage therapy for germ cell cancer using high dose chemotherapy with autologous bone marrow support Cancer 73 6 Mar 15 1994 1716 1720 (Pubitemid 24085275)
101. E.R. Broun, C.R. Nichols, G. Gize, K. Cornetta, R.A. Hromas, and B. Schacht Tandem high dose chemotherapy with autologous bone marrow transplantation for initial relapse of testicular germ cell cancer Cancer 79 8 Apr 15 1997 1605 1610 (Pubitemid 27154795)
102. H.J. Schmoll, K. Jordan, R. Huddart, M.P. Pes, A. Horwich, and K. Fizazi Testicular seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 21 Suppl 5 May 2010 v140 v146
103. L.H. Einhorn, S.D. Williams, A. Chamness, M.J. Brames, S.M. Perkins, and R. Abonour High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors N Engl J Med 357 4 Jul 26 2007 340 348 (Pubitemid 47124134)
104. De Giorgi U, Rosti G, Salvioni R, Papiani G, Ballardini M, Pizzocaro G, et al. Long-term outcome of salvage high-dose chemotherapy in patients with germ cell tumor with poor prognostic features. Urol Oncol, In Press, Corrected Proof, Available online 24 June 2009, ISSN 1078-1439, doi: 10.1016/j.urolonc. 2009.03.030.
105. N. Nicolai, A. Necchi, L. Gianni, L. Piva, D. Biasoni, and T. Torelli Long-term results of a combination of paclitaxel, cisplatin and gemcitabine for salvage therapy in male germ-cell tumours BJU Int 104 3 Aug 2009 340 346
106. C. Kollmannsberger, C. Nichols, and C. Bokemeyer Recent advances in management of patients with platinum-refractory testicular germ cell tumors Cancer 106 6 Mar 15 2006 1217 1226 (Pubitemid 43363897)
107. G. Sonpavde, T.E. Hutson, and B.J. Roth Management of recurrent testicular germ cell tumors Oncologist 12 1 Jan 2007 51 61 (Pubitemid 46143502)
108. J. Shamash, T. Powles, W. Ansell, J. Stebbing, K. Mutsvangwa, and P. Wilson GAMEC-a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours Br J Cancer 97 3 Aug 2007 308 314 (Pubitemid 47196738)
109. S.D. Fossa, S.P. Stenning, A. Gerl, A. Horwich, P.I. Clark, and P.M. Wilkinson Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours Br J Cancer 80 9 Jul 1999 1392 1399 (Pubitemid 29308608)
110. T. Shiraishi, T. Nakamura, K. Mikami, N. Takaha, A. Kawauchi, and T. Miki Salvage chemotherapy with paclitaxel and gemcitabine plus nedaplatin (TGN) as part of multidisciplinary therapy in patients with heavily pretreated cisplatin-refractory germ cell tumors Int J Clin Oncol 14 5 Oct 2009 436 441
111. Manchana T, Ittiwut C, Mutirangura A, Kavanagh JJ. Targeted therapies for rare gynaecological cancers. Lancet Oncol Jul 2010;11(7):685-93.
112. L.H. Looijenga, H. de Leeuw, M. van Oorschot, R.J. van Gurp, H. Stoop, and A.J. Gillis Stem cell factor receptor (c-KIT) codon 816 mutations predict development of bilateral testicular germ-cell tumors Cancer Res 63 22 Nov 15 2003 7674 7678 (Pubitemid 37466695)
113. L.H. Einhorn, M.J. Brames, M.C. Heinrich, C.L. Corless, and A. Madani Phase II study of imatinib mesylate in chemotherapy refractory germ cell tumors expressing KIT Am J Clin Oncol 29 1 Feb 2006 12 13 (Pubitemid 44356708)
114. W. Voigt, T. Kegel, G. Maher, K. Jordan, L. Muller, and H.J. Schmoll Bevacizumab plus high-dose ifosfamide, etoposide and carboplatin (HD-ICE) as third-line salvage chemotherapy induced an unexpected dramatic response in highly platinum refractory germ-cell cancer Ann Oncol 17 3 Mar 2006 531 533 (Pubitemid 43329599)
115. M. Mego, M. Reckova, Z. Sycova-Mila, J. Obertova, K. Brozmanova, and T. Salek Bevacizumab in a growing teratoma syndrome. Case report Ann Oncol 18 5 May 2007 962 963 (Pubitemid 47061294)
116. Feldman DR, Turkula S, Ginsberg MS, Ishill N, Patil S, Carousso M, et al. Phase II trial of sunitinib in patients with relapsed or refractory germ cell tumors. Invest New Drugs Aug;28(4):523-8.
117. O. Rick, T. Braun, W. Siegert, and J. Beyer Activity of thalidomide in patients with platinum-refractory germ-cell tumours Eur J Cancer 42 12 Aug 2006 1775 1779 (Pubitemid 44164596)
118. A. Yoshinaka, I. Fukasawa, T. Sakamoto, M. Tanaka, Y. Ota, and N. Inaba The fertility and pregnancy outcomes of the patients who underwent preservative operation followed by adjuvant chemotherapy for malignant ovarian tumors Arch Gynecol Obstet 264 3 Nov 2000 124 127
119. D.M. Gershenson Menstrual and reproductive function after treatment with combination chemotherapy for malignant ovarian germ cell tumors J Clin Oncol 6 2 Feb 1988 270 275 (Pubitemid 18065930)
120. D.M. Gershenson, A.M. Miller, V.L. Champion, P.O. Monahan, Q. Zhao, and D. Cella Reproductive and sexual function after platinum-based chemotherapy in long-term ovarian germ cell tumor survivors: a Gynecologic Oncology Group Study J Clin Oncol 25 19 Jul 1 2007 2792 2797 (Pubitemid 47123188)
121. J. Tangir, D. Zelterman, W. Ma, and P.E. Schwartz Reproductive function after conservative surgery and chemotherapy for malignant germ cell tumors of the ovary Obstet Gynecol 101 2 Feb 2003 251 257 (Pubitemid 36170125)
122. L.B. Travis, S.D. Fossa, S.J. Schonfeld, M.L. McMaster, C.F. Lynch, and H. Storm Second cancers among 40, 576 testicular cancer patients: focus on long-term survivors J Natl Cancer Inst 97 18 Sep 21 2005 1354 1365 (Pubitemid 41487803)
123. J. Pedersen-Bjergaard, G. Daugaard, S.W. Hansen, P. Philip, S.O. Larsen, and M. Rorth Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours Lancet 338 8763 Aug 10 1991 359 363
124. L.B. Travis, C. Beard, J.M. Allan, A.A. Dahl, D.R. Feldman, and J. Oldenburg Testicular cancer survivorship: research strategies and recommendations J Natl Cancer Inst Jun 28 2010
125. D. Matei, A.M. Miller, P. Monahan, D. Gershenson, Q. Zhao, and D. Cella Chronic physical effects and health care utilization in long-term ovarian germ cell tumor survivors: a Gynecologic Oncology Group study J Clin Oncol 27 25 Sep 1 2009 4142 4149
126. P.O. Monahan, V.L. Champion, Q. Zhao, A.M. Miller, D. Gershenson, and S.D. Williams Case-control comparison of quality of life in long-term ovarian germ cell tumor survivors: a Gynecologic Oncology Group study J Psychosoc Oncol 26 3 2008 19 42
127. Pippitt C.H. Jr., Cain J.M., and Hakes T.B. Primary chemotherapy and the role of second-look laparotomy in non-dysgerminomatous germ cell malignancies of the ovary Gynecol. Oncol. 31 1988 268 275
128. Susnerwala S.S., Pande S.C., Shrivastava S.K., and Dinshaw K.A. Dysgerminoma of the ovary: review of 27 cases J. Surg. Oncol. 46 1991 43 47
129. Wu P.C., Huang R.L., and Lang J.H. Treatment of malignant ovarian germ cell tumors with preservation of fertility: a report of 28 cases Gynecol. Oncol. 40 1991 2 6
130. Fujita M., Inoue M., and Tanizawa O. Retrospective review of 41 patients with endodermal sinus tumor of the ovary Int. J. Gynecol. Cancer 3 1993 329 335 (Pubitemid 23290123)
131. Chang F.H., Lai C.H., and Chu K.K. Treatment of malignant germ cell tumors of the ovary J. Formos. Med. Assoc. 93 1994 411 416
132. Mayordomo J.I., Paz-Ares L., and Rivera F. Ovarian and extragonadal malignant germ-cell tumors in females: a single-institution experience with 43 patients Ann. Oncol. 5 1994 225 231 (Pubitemid 24097516)
133. Segelov E., Campbell J., and Ng M. Cisplatin-based chemotherapy for ovarian germ cell malignancies: the Australian experience J. Clin. Oncol. 12 1994 378 384 (Pubitemid 24056413)
134. Peccatori F., Bonazzi C., and Chiari S. Surgical management of malignant ovarian germ-cell tumors: 10 years' experience of 129 patients Obstet. Gynecol. 86 1995 367 372
135. Piura B., Dgani R., and Zalel Y. Malignant germ cell tumors of the ovary: a study of 20 cases J. Surg. Oncol. 59 1995 155 161
136. Culine S., Lhomme C., and Kattan J. Cisplatin-based chemotherapy in the management of germ cell tumors of the ovary: The Institut Gustave Roussy Experience Gynecol. Oncol. 64 1997 160 165 (Pubitemid 27026976)
137. Zhang R., Hong W., and Liu L. [Treatment of malignant germ cell tumors of the ovary: a clinical analysis of 233 cases] Zhonghua Zhong Liu Za Zhi 20 1998 155 157
138. Cusido M.T., Jorda B., and Gonzalez J. Ovarian germ cell tumors Eur. J. Gynaecol. Oncol. 19 1998 130 134 (Pubitemid 28171299)
139. Mitchell P.L., Al-Nasiri N., and A'Hern R. Treatment of nondysgerminomatous ovarian germ cell tumors: an analysis of 69 cases Cancer 85 1999 2232 2244 (Pubitemid 29215564)
140. Brewer M., Gershenson D.M., and Herzog C.E. Outcome and reproductive function after chemotherapy for ovarian dysgerminoma J. Clin. Oncol. 17 1999 2670 2675 (Pubitemid 29415222)
141. Linasmita V., Srisupundit S., and Wilailak S. Recent management of malignant ovarian germ cell tumors: a study of 34 cases J. Obstet. Gynaecol. Res. 25 1999 315 320 (Pubitemid 29500370)
142. El-Lamie I.K., Shehata N.A., Abou-Loz S.K., and El-Lamie K.I. Conservative surgical management of malignant ovarian germ cell tumors: the experience of the Gynecologic Oncology Unit at Ain Shams University Eur. J. Gynaecol. Oncol. 21 2000 605 609 (Pubitemid 32164829)
143. Ayhan A., Bildirici I., Gunalp S., and Yuce K. Pure dysgerminoma of the ovary: a review of 45 well staged cases Eur. J. Gynaecol. Oncol. 21 2000 98 101 (Pubitemid 30088102)
144. Khi C., Low J.J., and Tay E.H. Malignant ovarian germ cell tumors: the KK Hospital experience Eur. J. Gynaecol. Oncol. 23 2002 251 256 (Pubitemid 34625334)
145. Lertkhachonsuk R., Termrungruanglert W., and Vasuratna A. Malignant
146. Miki T., Mizutani Y., and Nonomura N. Irinotecan plus cisplatin has substantial antitumor effect as salvage chemotherapy against germ cell tumors Cancer 95 2002 1879 1885 (Pubitemid 35222167)
147. Hinton S., Catalano P., and Einhorn L.H. Phase II study of paclitaxel plus gemcitabine in refractory germ cell tumors (E9897): a trial of the Eastern Cooperative Oncology Group J. Clin. Oncol. 20 2002 1859 1863 (Pubitemid 34273277)
148. Kollmannsberger C., Beyer J., and Liersch R. Combination chemotherapy with gemcitabine plus oxaliplatin in patients with intensively pretreated or refractory germ cell cancer: a study of the German Testicular Cancer Study Group J. Clin. Oncol. 22 2004 108 114 (Pubitemid 41095121)
149. Pectasides D., Pectasides M., and Farmakis D. Gemcitabine and oxaliplatin (GEMOX) in patients with cisplatin-refractory germ cell tumors: a phase II study Ann. Oncol. 15 2004 493 497 (Pubitemid 38444556)
150. Pectasides D., Pectasides M., and Farmakis D. Oxaliplatin and irinotecan plus granulocyte-colony stimulating factor as third-line treatment in relapsed or cisplatin-refractory germ-cell tumor patients: a phase II study Eur. Urol. 46 2004 216 221 (Pubitemid 38902741)
151. Einhorn L.H., Brames M.J., Juliar B., and Williams S.D. Phase II study of paclitaxel plus gemcitabine salvage chemotherapy for germ cell tumors after progression following high-dose chemotherapy with tandem transplant J. Clin. Oncol. 25 2007 513 516 (Pubitemid 350002957)
152. Theodore C., Chevreau C., and Yataqhene Y. A phase II multicenter study of oxaliplatin in combination with paclitaxel in poor prognosis patients who failed cisplatin-based chemotherapy for germ-cell tumors Ann. Oncol. 19 2008 1465 1469